Kirk Henne serves as Head of Translational Pharmacology and Bioanalysis at Denali. In this role, he supports Drug Metabolism and Pharmacokinetics, Quantitative Pharmacology, Metabolomics and Proteomics, and Bioanalytical teams to advance Denali's biotherapeutic and small molecule portfolio.
Currently, there are no issues on this topic.